Annual Long Term Debt
$264.62 M
+$4.05 M+1.56%
31 December 2023
Summary:
Esperion Therapeutics annual long term debt is currently $264.62 million, with the most recent change of +$4.05 million (+1.56%) on 31 December 2023. During the last 3 years, it has risen by +$81.80 million (+44.74%). ESPR annual long term debt is now at all-time high.ESPR Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$266.22 M
-$235.00 K-0.09%
30 September 2024
Summary:
Esperion Therapeutics quarterly long term debt is currently $266.22 million, with the most recent change of -$235.00 thousand (-0.09%) on 30 September 2024. Over the past year, it has increased by +$3.01 million (+1.14%). ESPR quarterly long term debt is now -2.91% below its all-time high of $274.21 million, reached on 31 March 2021.ESPR Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.6% | +1.1% |
| 3 y3 years | +44.7% | -2.8% |
| 5 y5 years | +100.0% | +10000.0% |
ESPR Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +44.7% | -2.8% | +2.9% |
| 5 y | 5 years | at high | -2.9% | >+9999.0% | |
| alltime | all time | at high | -2.9% |
Esperion Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $266.22 M(-0.1%) |
| June 2024 | - | $266.46 M(+0.0%) |
| Mar 2024 | - | $266.45 M(+0.7%) |
| Dec 2023 | $264.62 M(+1.6%) | $264.62 M(+0.5%) |
| Sept 2023 | - | $263.21 M(+0.3%) |
| June 2023 | - | $262.44 M(+0.5%) |
| Mar 2023 | - | $261.10 M(+0.2%) |
| Dec 2022 | $260.56 M(+0.7%) | $260.56 M(+0.4%) |
| Sept 2022 | - | $259.53 M(+0.1%) |
| June 2022 | - | $259.21 M(+0.1%) |
| Mar 2022 | - | $258.94 M(+0.1%) |
| Dec 2021 | $258.80 M(+41.6%) | $258.80 M(-5.5%) |
| Sept 2021 | - | $273.82 M(-0.1%) |
| June 2021 | - | $274.02 M(-0.1%) |
| Mar 2021 | - | $274.21 M(+50.0%) |
| Dec 2020 | $182.82 M(>+9900.0%) | $182.82 M(+4353.6%) |
| Sept 2020 | - | $4.11 M(+3.5%) |
| June 2020 | - | $3.97 M(+6.7%) |
| Mar 2020 | - | $3.72 M(+235.3%) |
| Dec 2019 | $1.11 M | $1.11 M(+35.2%) |
| Sept 2019 | - | $820.00 K(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $759.00 K(-4.2%) |
| Mar 2019 | - | $792.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2017 | - | $140.00 K(-76.1%) |
| Mar 2017 | - | $585.00 K(-42.8%) |
| Dec 2016 | $1.02 M(-62.0%) | $1.02 M(-29.6%) |
| Sept 2016 | - | $1.45 M(-22.4%) |
| June 2016 | - | $1.87 M(-18.0%) |
| Mar 2016 | - | $2.28 M(-15.1%) |
| Dec 2015 | $2.69 M(-36.5%) | $2.69 M(-12.8%) |
| Sept 2015 | - | $3.08 M(-11.2%) |
| June 2015 | - | $3.47 M(-9.9%) |
| Mar 2015 | - | $3.85 M(-8.9%) |
| Dec 2014 | $4.23 M(-43.8%) | $4.23 M(-9.5%) |
| Sept 2014 | - | $4.68 M(-5.0%) |
| June 2014 | - | $4.92 M(-34.6%) |
| Dec 2012 | $7.53 M(+9.2%) | $7.53 M |
| Dec 2011 | $6.90 M(-10.8%) | - |
| Dec 2002 | $7.73 M(+41.0%) | - |
| Dec 2001 | $5.48 M(+81.1%) | - |
| Dec 2000 | $3.03 M(+32.5%) | - |
| Dec 1999 | $2.28 M | - |
FAQ
- What is Esperion Therapeutics annual long term debt?
- What is the all time high annual long term debt for Esperion Therapeutics?
- What is Esperion Therapeutics annual long term debt year-on-year change?
- What is Esperion Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly long term debt year-on-year change?
What is Esperion Therapeutics annual long term debt?
The current annual long term debt of ESPR is $264.62 M
What is the all time high annual long term debt for Esperion Therapeutics?
Esperion Therapeutics all-time high annual long term debt is $264.62 M
What is Esperion Therapeutics annual long term debt year-on-year change?
Over the past year, ESPR annual long term debt has changed by +$4.05 M (+1.56%)
What is Esperion Therapeutics quarterly long term debt?
The current quarterly long term debt of ESPR is $266.22 M
What is the all time high quarterly long term debt for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly long term debt is $274.21 M
What is Esperion Therapeutics quarterly long term debt year-on-year change?
Over the past year, ESPR quarterly long term debt has changed by +$3.01 M (+1.14%)